Skip to main content
Caplight Logo









Morphic Medical

Morphic Medical

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://morphicmedical.com/home-2/

Last Round

Private Equity

Feb 16, 2026

Est. Valuation

$205.6M

Total Funding Raised

$15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Morphic Medical is a therapeutic devices company that has developed RESET®, an endoscopically delivered device therapy for the treatment of type 2 diabetes and obesity.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

duodenal-jejunal bypass linermetabolic deviceendoscopic bariatric therapyendobariatricsobesity treatmenttype 2 diabetes treatmentnon-surgical bariatricDJBLminimally invasive devicereversible obesity treatmentendoscopic weight lossglycemic controlmedical device commercializationclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Morphic Medical Comparables

Compare Morphic Medical with similar companies based on industry and business-model similarity.

Morphic Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EndoSphere
84%
Fractyl Health
81%
Cortex, Inc.
81%

Morphic Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityFeb 16, 2026
Convertible DebtDec 3, 2024
Private PlacementSep 4, 2020
Private PlacementJan 23, 2018

Key People

Founding team and executive leadership

jane wright

Chief Financial Officer

Executive Team

Morphic Medical Investors

Notable investors and investment history

Morphic Medical investors
InvestorRounds
Crystal Amber FundConvertible Debt, Private Equity, Private Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 46% MoM.

  • Feb 22, 2026

    Grew 16% QoQ, from 50 to 58 employees.

Morphic Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Morphic Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Morphic Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range27
Year Founded2003
Last FundingFeb 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?